These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12969761)

  • 1. Antidiabetic effect of chronic administration of JTT-608, a new hypoglycemic agent, in diabetic Goto-Kakizaki rats.
    Ohta T; Miyajima K; Komuro G; Furukawa N; Yonemori F
    Eur J Pharmacol; 2003 Aug; 476(1-2):159-66. PubMed ID: 12969761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily inhibition of postprandial hyperglycaemia with JTT-608, a novel oral antidiabetic agent, ameliorates pancreatic function in neonatally streptozotocin-treated rats.
    Ohta T; Sasase T; Miyajima K; Matsui K; Matsushita M; Furukawa N; Yonemori F
    Diabetes Obes Metab; 2005 Sep; 7(5):517-24. PubMed ID: 16050944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats.
    Ohta T; Furukawa N; Komuro G; Yonemori F; Wakitani K
    Br J Pharmacol; 1999 Apr; 126(7):1674-80. PubMed ID: 10323602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JTT-608 controls blood glucose by enhancement of glucose-stimulated insulin secretion in normal and diabetes mellitus rats.
    Ohta T; Furukawa N; Yonemori F; Wakitani K
    Eur J Pharmacol; 1999 Feb; 367(1):91-9. PubMed ID: 10082270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-(trans-4-Methylcyclohexyl)-4-oxobutyric acid (JTT-608). A new class of antidiabetic agent.
    Shinkai H; Ozeki H; Motomura T; Ohta T; Furukawa N; Uchida I
    J Med Chem; 1998 Dec; 41(27):5420-8. PubMed ID: 9876112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-dependent insulinotropic effects of JTT-608, a novel antidiabetic compound.
    Furukawa N; Ohta T; Noguchi T; Yonemori F; Wakitani K
    Eur J Pharmacol; 1999 Apr; 371(1):51-8. PubMed ID: 10355594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased blood glucose excursion by nateglinide ameliorated neuropathic changes in Goto-Kakizaki rats, an animal model of non-obese type 2 diabetes.
    Kitahara Y; Miura K; Takesue K; Mine T; Wada R; Uchida Y; Ito S; Yagihashi S
    Metabolism; 2002 Nov; 51(11):1452-7. PubMed ID: 12404197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The insulinotropic mechanism of the novel hypoglycaemic agent JTT-608: direct enhancement of Ca(2+) efficacy and increase of Ca(2+) influx by phosphodiesterase inhibition.
    Mukai E; Ishida H; Fujimoto S; Kajikawa M; Okamoto Y; Fujita J; Hamamoto Y; Tsuura Y; Yamada Y; Furukawa N; Ohta T; Seino Y
    Br J Pharmacol; 2000 Mar; 129(5):901-8. PubMed ID: 10696088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative.
    Shibata T; Matsui K; Nagao K; Shinkai H; Yonemori F; Wakitani K
    Eur J Pharmacol; 1999 Jan; 364(2-3):211-9. PubMed ID: 9932726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of KIOM-79 on hyperglycemia and diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats.
    Kim CS; Sohn EJ; Kim YS; Jung DH; Jang DS; Lee YM; Kim DH; Kim JS
    J Ethnopharmacol; 2007 May; 111(2):240-7. PubMed ID: 17194556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.
    Itabashi N; Okada K; Muto S; Fujita N; Ohta T; Miyazaki Ji ; Asano Y; Saito T
    J Pharmacol Exp Ther; 2001 Jun; 297(3):953-60. PubMed ID: 11356916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide.
    Hashiguchi S; Yada T; Arima T
    J Pharmacol Exp Ther; 2001 Jan; 296(1):22-30. PubMed ID: 11123358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiabetic effect of orally administered conophylline-containing plant extract on streptozotocin-treated and Goto-Kakizaki rats.
    Fujii M; Takei I; Umezawa K
    Biomed Pharmacother; 2009 Dec; 63(10):710-6. PubMed ID: 19217246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TMG-123, a novel glucokinase activator, exerts durable effects on hyperglycemia without increasing triglyceride in diabetic animal models.
    Tsumura Y; Tsushima Y; Tamura A; Hasebe M; Kanou M; Kato H; Kobayashi T
    PLoS One; 2017; 12(2):e0172252. PubMed ID: 28207836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of hypoglycemic activity of total lignans from Fructus Arctii in the spontaneously diabetic Goto-Kakizaki rats.
    Xu Z; Ju J; Wang K; Gu C; Feng Y
    J Ethnopharmacol; 2014; 151(1):548-55. PubMed ID: 24269245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JTT-501, a new oral hypoglycemic agent, reverses hypertriglyceridemia in Zucker fatty and ventromedial hypothalamus-lesioned obese rats.
    Yamazaki Y; Osaka T; Murakami T; Inoue S
    Metabolism; 2000 May; 49(5):574-8. PubMed ID: 10831165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JTT-501, a novel oral antidiabetic agent, improves insulin resistance in genetic and non-genetic insulin-resistant models.
    Shibata T; Matsui K; Yonemori F; Wakitani K
    Br J Pharmacol; 1998 Dec; 125(8):1744-50. PubMed ID: 9886766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of magnolol (5,5'-diallyl-2,2'-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats.
    Sohn EJ; Kim CS; Kim YS; Jung DH; Jang DS; Lee YM; Kim JS
    Life Sci; 2007 Jan; 80(5):468-75. PubMed ID: 17070554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of hypoglycemic effects of an intestine-specific inhibitor of microsomal triglyceride transfer protein (MTP) in obese rats.
    Sakata S; Katsumi S; Mera Y; Kuroki Y; Nashida R; Kakutani M; Ohta T
    J Pharmacol Sci; 2015 Jan; 127(1):103-8. PubMed ID: 25704025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gliquidone decreases urinary protein by promoting tubular reabsorption in diabetic Goto-Kakizaki rats.
    Ke JT; Li M; Xu SQ; Zhang WJ; Jiang YW; Cheng LY; Chen L; Lou JN; Wu W
    J Endocrinol; 2014 Feb; 220(2):129-41. PubMed ID: 24254365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.